Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-18

Clinical Trial Update: HIV - Monotherapy in Switzerland (MOST-ch) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating HIV monotherapy in Switzerland (MOST-ch) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cantonal Hospital of St. Gallen | Conditions: HIV Infections | Phase 4 | Status: TERMINATED